LAPOINTE ANTHONY GREGG has filed 15 insider transactions across 3 companies since May 2023.
Most recent transaction: a disposition of 16666 shares of Astria Therapeutics, Inc. ($ATXS) on January 23, 2026.
| Transaction Date | Company | Ticker | Insider Name | Title | Transaction Type | Security | Shares | Price | Shares Owned Following | Total Shares Outstanding | % of Owned | % of Outstanding |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Jan. 23, 2026 | Astria Therapeutics, Inc. | $ATXS | LAPOINTE ANTHONY GREGG | Not found | D | Stock Option (Right to Buy) | 16666 | $0.00 | 0.0000 | 58,005,928 | 100.00% | 0.03% |
| Jan. 23, 2026 | Astria Therapeutics, Inc. | $ATXS | LAPOINTE ANTHONY GREGG | Not found | D | Stock Option (Right to Buy) | 26550 | $0.00 | 0.0000 | 58,005,928 | 100.00% | 0.05% |
| Jan. 23, 2026 | Astria Therapeutics, Inc. | $ATXS | LAPOINTE ANTHONY GREGG | Not found | D | Stock Option (Right to Buy) | 14100 | $0.00 | 0.0000 | 58,005,928 | 100.00% | 0.02% |
| Jan. 23, 2026 | Astria Therapeutics, Inc. | $ATXS | LAPOINTE ANTHONY GREGG | Not found | D | Stock Option (Right to Buy) | 14100 | $0.00 | 0.0000 | 58,005,928 | 100.00% | 0.02% |
| Jan. 23, 2026 | Astria Therapeutics, Inc. | $ATXS | LAPOINTE ANTHONY GREGG | Not found | D | Stock Option (Right to Buy) | 8333 | $0.00 | 0.0000 | 58,005,928 | 100.00% | 0.01% |
| June 20, 2025 | SOLIGENIX, INC. | $SNGX | LAPOINTE ANTHONY GREGG | Not found | A | Stock Option (Right to Buy) | 17647 | $0.00 | 17,647.0000 | 3,049,625 | 9999.99% | 0.58% |
| June 11, 2025 | Astria Therapeutics, Inc. | $ATXS | LAPOINTE ANTHONY GREGG | Director | A | Stock Option (Right to Buy) | 26550 | $0.00 | 26,550.0000 | 58,005,312 | 9999.99% | 0.05% |
| May 23, 2025 | RIGEL PHARMACEUTICALS INC | $RIGL | LAPOINTE ANTHONY GREGG | Not found | A | Stock Option (Right to Buy) | 3000 | $0.00 | 3,000.0000 | 18,169,000 | 9999.99% | 0.02% |
| May 23, 2025 | RIGEL PHARMACEUTICALS INC | $RIGL | LAPOINTE ANTHONY GREGG | Not found | A | Common Stock | 2500 | $0.00 | 12,500.0000 | 18,169,000 | 25.00% | 0.01% |
| Dec. 12, 2024 | SOLIGENIX, INC. | $SNGX | LAPOINTE ANTHONY GREGG | Not found | A | Stock Option (Right to Buy) | 8646 | $0.00 | 8,646.0000 | 2,203,929 | 9999.99% | 0.39% |
| June 5, 2024 | Astria Therapeutics, Inc. | $ATXS | LAPOINTE ANTHONY GREGG | Director | A | Stock Option (Right to Buy) | 14100 | $0.00 | 14,100.0000 | 52,294,765 | 9999.99% | 0.03% |
| May 25, 2024 | RIGEL PHARMACEUTICALS INC | $RIGL | LAPOINTE ANTHONY GREGG | Not found | A | Common Stock | 25000 | $0.00 | 100,000.0000 | 17,520,000 | 33.33% | 0.14% |
| May 25, 2024 | RIGEL PHARMACEUTICALS INC | $RIGL | LAPOINTE ANTHONY GREGG | Not found | A | Stock Option (Right to Buy) | 30000 | $0.00 | 30,000.0000 | 17,520,000 | 9999.99% | 0.17% |
| May 26, 2023 | RIGEL PHARMACEUTICALS INC | $RIGL | LAPOINTE ANTHONY GREGG | Not found | A | Stock Option (Right to Buy) | 30000 | $0.00 | 30,000.0000 | 173,568,000 | 9999.99% | 0.02% |
| May 26, 2023 | RIGEL PHARMACEUTICALS INC | $RIGL | LAPOINTE ANTHONY GREGG | Not found | A | Common Stock | 25000 | $0.00 | 75,000.0000 | 173,568,000 | 50.00% | 0.01% |